(2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Innovation in Pharmaceutical Tachnology, BioPharma UK, Biopharma.Īdams, G.P., et al. (2009) The emergence of antibody fragments and derivatives. Biochemical Society Transactions, 30, 512-516.

(2002) Formatting antibody fragments to mediate specific therapeutic functions. and Dübel, S., Eds., Antibody Engineering, Springer Berlin Heidelberg, Berlin, Heidelberg, 301-315. (2010) Analysis and purification of antibody fragments using protein A, protein G, and protein L. Protein Expression and Purification, 67, 182-189. (2009) Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells. (2008) Expression of Fab fragments in CHO and Pichia pastoris. and Dübel, S., Eds., Antibody Engineering, Springer Berlin Heidelberg, Berlin, Heidelberg, 331-344. (2010) Production of antibodies and antibody fragments in Escherichia coli. and Dübel, S., Eds., Antibody Engineering, Springer Berlin Heidelberg, Berlin, Heidelberg, 293-299. (2010) Production of antibody fragments in the gram-positive bacterium Bacillus megaterium. Clinical Pharmacology & Therapeutics, 84, 548-558. (2008) Monoclonal antibody pharmacokinetics and pharmaco-dynamics. (2008) Protein therapeutics: A summary and pharmacological classification. (2012) Recent trends in antibody-based oncologic imaging. (2009) Development trends for therapeutic antibody fragments. (2011) Antibody conjugate therapeutics: Challenges and potential. Brazilian Journal of Pharmaceutical Sciences, 47, 31-38. (2011) Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals. (2005) Tailor-made antibody therapeutics. Multi-Agent-Based Simulation, 2, 77-83.Ĭhowdhury, P.S.

(2010) Antibody fragments: Hope and hype. (2005) Engineered antibody fragments and the rise of single domains. (2003) Antibodies in proteomics I: Generating antibodies. (1999) Therapeutic antibody fragments with prolonged in vivo half-lives.

Half life 2 annabelle